- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Abbott Laboratories Pakistan Ltd (ABBT)
Abbott Laboratories Pakistan Ltd stock price live, this page displays PSX ABBT stock exchange data. View the ABBT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Abbott Laboratories Pakistan Ltd real time stock price chart below.
What Is the Abbott Laboratories Pakistan Ltd Stock Price Today?
The Abbott Laboratories Pakistan Ltd stock price today is 883.75.
What Is the Stock Symbol for Abbott Laboratories Pakistan Ltd?
The stock symbol for Abbott Laboratories Pakistan Ltd is "ABBT."
What Stock Exchange Does Abbott Laboratories Pakistan Ltd Trade On?
Abbott Laboratories Pakistan Ltd is listed and trades on the Karachi stock exchange.
Is Abbott Laboratories Pakistan Ltd a Good Stock to Buy?
Determining whether Abbott Laboratories Pakistan Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ABBT quote. (ISIN: PK0025701019)
What Is the Abbott Laboratories Pakistan Ltd Stock Price Today?
The Abbott Laboratories Pakistan Ltd stock price today is 883.75.
What Is the Stock Symbol for Abbott Laboratories Pakistan Ltd?
The stock symbol for Abbott Laboratories Pakistan Ltd is "ABBT."
What Stock Exchange Does Abbott Laboratories Pakistan Ltd Trade On?
Abbott Laboratories Pakistan Ltd is listed and trades on the Karachi stock exchange.
Is Abbott Laboratories Pakistan Ltd a Good Stock to Buy?
Determining whether Abbott Laboratories Pakistan Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ABBT quote. (ISIN: PK0025701019)
Karachi
Currency in PKR
883.75
+12.60(+1.45%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
880.00
896.99
52 wk Range
821.00
1,304.00
Earnings results expected today
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
880.00896.99
52 wk Range
821.001,304.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.64%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.64%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
ABBT Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
1,300.00
Upside
+47.10%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 1,300.00
(+47.10% Upside)
Earnings
Latest Release
May 26, 2026
EPS / Forecast
19.82 / --
Revenue / Forecast
17.7B / --
Compare ABBT to Peers and Sector
Metrics to compare | ABBT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipABBTPeersSector | |
|---|---|---|---|---|
P/E Ratio | 10.4x | 16.0x | −0.5x | |
PEG Ratio | 0.19 | 0.48 | 0.00 | |
Price/Book | 2.6x | 3.1x | 2.6x | |
Price / LTM Sales | 1.1x | 1.7x | 3.1x | |
Upside (Analyst Target) | 47.1% | 15.7% | 52.5% | |
Fair Value Upside | Unlock | 25.7% | 6.0% | Unlock |
Abbott Laboratories (Pakistan) Limited manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland. It operates through Pharmaceutical, Nutritional, Diagnostics, and Others segments. The company engages in the manufacturing, importing, and marketing of branded generic pharmaceutical products; and import and marketing of nutritional products. It also imports and markets diagnostic equipment, molecular devices, and testing kits; and manufactures and markets diabetes care and general healthcare products. The company offers its products under the Brufen, Surbex Z, Duphaston, Arinac, Ensure, Pediasure, Glucerna, FreeStyle Libre, and Alinity brand names. It also exports its products. The company was founded in 1888 and is based in Karachi, Pakistan. Abbott Laboratories (Pakistan) Limited operates as a subsidiary of Abbott Asia Investments Ltd.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Abbott Laboratories Pakistan (ABBT) Stock Price Today?
The Abbott Laboratories Pakistan stock price today is 883.75 PKR.
What Stock Exchange Does Abbott Laboratories Pakistan Trade On?
Abbott Laboratories Pakistan is listed and trades on the Karachi Stock Exchange.
What Is the Stock Symbol for Abbott Laboratories Pakistan?
The stock symbol for Abbott Laboratories Pakistan is "ABBT."
Does Abbott Laboratories Pakistan Pay Dividends? What’s The Current Dividend Yield?
The Abbott Laboratories Pakistan dividend yield is 4.64%.
What Is the Abbott Laboratories Pakistan Market Cap?
As of today, Abbott Laboratories Pakistan market cap is 86.52B PKR.
What Is Abbott Laboratories Pakistan's Earnings Per Share (TTM)?
The Abbott Laboratories Pakistan EPS (TTM) is 84.85.
When Is the Next Abbott Laboratories Pakistan Earnings Date?
Abbott Laboratories Pakistan will release its next earnings report on May 26, 2026.
From a Technical Analysis Perspective, Is ABBT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Abbott Laboratories Pakistan Stock Split?
Abbott Laboratories Pakistan has split 10 times.
How Many Employees Does Abbott Laboratories Pakistan Have?
Abbott Laboratories Pakistan has 1380 employees.
What is the current trading status of Abbott Laboratories Pakistan (ABBT)?
As of May 26, 2026, Abbott Laboratories Pakistan (ABBT) is trading at a price of 883.75 PKR, with a previous close of 871.15 PKR. The stock has fluctuated within a day range of 880.00 PKR to 896.99 PKR, while its 52-week range spans from 821.00 PKR to 1,304.00 PKR.
What Is Abbott Laboratories Pakistan (ABBT) Price Target According to Analysts?
The average 12-month price target for Abbott Laboratories Pakistan is 1,300.00 PKR, with a high estimate of 1300 PKR and a low estimate of 1300 PKR. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +47.10% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.